Physician profile
Mimi M Chen
NPI 1003865874
$2,701.68
in general payments reported to CMS, 2019-2025
20 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $72.45 · 2021: $68.85 · 2022: $901 · 2023: $762 · 2024: $440 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,418.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $635.38 | 2019-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Acessa Provu System |
| Aspira Women'S Health INC | $331.86 | 2020-2024 | Ova1 |
| Abbvie INC. | $294.04 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $254.35 | 2022-2024 | Veozah |
| Sumitomo Pharma America, INC. | $195.76 | 2023-2024 | Myfembree |
| Coopersurgical, INC. | $178.37 | 2021-2023 | Summit Doppler, Paragard T 380a |
| Axonics, INC. | $141.66 | 2023-2024 | Bulkamid, Axonics |
| Organogenesis INC. | $135.35 | 2025 | Affinity, Puraply Wound Matrix, Apligraf |
| Organon LLC | $124.41 | 2022-2024 | Nexplanon |
| Myovant Sciences INC. | $109.62 | 2022 | |
| Pfizer INC. | $88.85 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $56.95 | 2019-2023 | Gardasil 9 |
| Therapeuticsmd, INC. | $39.73 | 2019-2022 | |
| Biogen, INC. | $20.22 | 2024 | |
| Becton, Dickinson and Company | $18.75 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $18.50 | 2019 | |
| Exeltis, USA INC. | $16.30 | 2019 | |
| Mayne Pharma Commercial LLC | $15.41 | 2023 | |
| Medicem INC. | $14.18 | 2023 | |
| Allergan, INC. | $11.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mimi Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.